What Is Calcium Alpha-Ketoglutarate?
Calcium alpha-ketoglutarate (Ca-AKG) is the calcium salt of alpha-ketoglutarate, a naturally occurring molecule that plays a central role in the tricarboxylic acid (TCA) cycle — the metabolic pathway your mitochondria use to generate cellular energy. Alpha-ketoglutarate (AKG) is also a key nitrogen transporter and a cofactor for a family of enzymes called alpha-ketoglutarate-dependent dioxygenases, which include the ten-eleven translocation (TET) enzymes and Jumonji-domain histone demethylases involved in epigenetic regulation.
As we age, circulating levels of AKG decline. Plasma concentrations of AKG in older adults can be as much as 10-fold lower than in younger individuals. This age-related decline has prompted researchers to investigate whether restoring AKG levels through supplementation could slow aspects of biological aging.
The calcium salt form (Ca-AKG) is preferred in supplements because it provides better stability and bioavailability compared to free alpha-ketoglutarate. The most well-known commercial formulation is Rejuvant LifeAKG, which combines Ca-AKG with vitamins A and D.
The Science Behind Ca-AKG and Aging
TCA Cycle and Cellular Energy
Alpha-ketoglutarate sits at a critical junction in the TCA cycle, positioned between isocitrate and succinyl-CoA. It serves as both an energy substrate and a signaling molecule. When AKG levels are adequate, mitochondrial function tends to be more efficient, supporting ATP production across tissues with high metabolic demand — brain, heart, skeletal muscle, and immune cells.
Beyond energy metabolism, AKG acts as a substrate for prolyl hydroxylases (PHDs), which regulate hypoxia-inducible factor (HIF) signaling. This pathway influences everything from red blood cell production to inflammatory responses, connecting AKG to broad physiological effects.
Epigenetic Age Modulation
Perhaps the most exciting aspect of Ca-AKG research involves its potential to influence epigenetic aging. The TET enzymes, which require AKG as a cofactor, catalyze the oxidation of 5-methylcytosine (5mC) to 5-hydroxymethylcytosine (5hmC), initiating the DNA demethylation pathway. Age-related changes in DNA methylation patterns — the so-called "epigenetic clock" — are among the most reliable biomarkers of biological aging.
The hypothesis is straightforward: by providing more AKG, you support TET enzyme activity, which may help maintain more youthful DNA methylation patterns. This is the theoretical framework that makes Ca-AKG distinct from many other longevity supplements — it directly feeds into the enzymatic machinery that controls epigenetic marks.
Inflammation and Immune Function
AKG also appears to modulate inflammatory signaling. Preclinical research suggests it can suppress NF-κB activation and reduce production of pro-inflammatory cytokines like IL-6 and TNF-α. Since chronic low-grade inflammation ("inflammaging") is considered a hallmark of aging, this anti-inflammatory effect could contribute to any longevity benefits.
Key Studies on Ca-AKG
Mouse Lifespan Study (Asadi Shahmirzadi et al., 2020)
The foundational animal study was published in *Cell Metabolism* by Asadi Shahmirzadi and colleagues at the Buck Institute for Research on Aging. In this study, mice were fed Ca-AKG starting at 18 months of age (roughly equivalent to middle age in humans).
The results were striking:
- Female mice showed a median lifespan extension of approximately 12%
- Male mice showed no statistically significant lifespan extension, but did show improvements in healthspan measures
- Both sexes showed reduced frailty indices, including better fur quality, improved gait, and reduced hair loss
- Ca-AKG-treated mice had lower levels of systemic inflammatory cytokines, particularly IL-6
- The treatment appeared to compress morbidity — meaning the mice spent a greater proportion of their lives in good health
Importantly, this study used Ca-AKG at a dose of approximately 2% of food weight, which translates to a human-equivalent dose in the range of 1,000–1,500 mg/day depending on body weight assumptions.
The sex-specific difference in lifespan extension is notable and not fully explained. The researchers hypothesized that hormonal differences, particularly estrogen's interaction with TCA cycle metabolism, may play a role.
Human Biological Age Trial (Demidenko et al., 2021)
The first human trial of Ca-AKG for biological aging was published in *Aging* by Demidenko and colleagues. This was an open-label, retrospective analysis of 42 volunteers (average age ~63 years) who took Rejuvant LifeAKG (containing ~1,000 mg Ca-AKG daily) for an average of 7 months.
Biological age was assessed using the TruAge DNA methylation test (based on the DunedinPACE and other epigenetic clock algorithms). The key findings:
- Average biological age reduction of 8 years as measured by DNA methylation clocks
- The effect was statistically significant (p < 0.001)
- Subgroup analyses suggested the effect was consistent across both men and women
- No serious adverse events were reported during the study period
However, this study has significant limitations that must be acknowledged:
1. No placebo control group — without a control, it's impossible to rule out placebo effects, regression to the mean, or lifestyle changes during the study period
2. Open-label design — participants knew they were taking a longevity supplement, which could influence behavior and bias subjective outcomes
3. Small sample size — 42 participants is too few to draw definitive conclusions
4. Conflict of interest — several authors were affiliated with Ponce de Leon Health, the company that manufactures Rejuvant
5. Retrospective analysis — the study was not a prospective randomized trial
These are not reasons to dismiss the results, but they mean we should treat the 8-year biological age reduction claim with appropriate caution. The results are hypothesis-generating, not definitive.
Dosage and Supplementation
Typical Dosage
Most Ca-AKG supplements, including Rejuvant, provide approximately 1,000 mg of Ca-AKG per day, typically split into two 500 mg doses taken with meals. This dose is broadly consistent with the allometric scaling from the mouse studies.
Some longevity enthusiasts report using doses up to 2,000 mg/day, though there is no human evidence that higher doses provide additional benefit.
Timing and Absorption
Ca-AKG is generally taken with food to minimize potential gastrointestinal discomfort. The calcium component provides approximately 200 mg of elemental calcium per 1,000 mg of Ca-AKG, which should be factored into total daily calcium intake.
AKG is rapidly metabolized after absorption, with plasma levels peaking within 1–2 hours. Some researchers have suggested that a sustained-release formulation might be more effective, though this has not been tested in clinical trials.
Safety Profile
Ca-AKG has a favorable safety profile based on available data:
- Alpha-ketoglutarate is an endogenous metabolite — your body already produces and uses it
- No serious adverse events have been reported in published human studies
- The most commonly reported side effects are mild gastrointestinal symptoms (bloating, nausea) that typically resolve within the first week
- The calcium content could be a concern for individuals with hypercalcemia or those already taking high-dose calcium supplements
- AKG may interact with amino acid metabolism, so individuals with certain metabolic disorders should consult a physician
How Ca-AKG Compares With Other Longevity Supplements
Ca-AKG vs. NAD+ Precursors (NR and NMN)
Nicotinamide riboside (NR) and nicotinamide mononucleotide (NMN) aim to boost NAD+ levels, supporting sirtuin activity and mitochondrial function. Ca-AKG works through a different mechanism — epigenetic regulation via TET enzymes and TCA cycle support. These pathways are complementary rather than competitive, and some longevity researchers take both. However, NR and NMN have more published human trials, even though none have demonstrated lifespan extension in humans.
Ca-AKG vs. Resveratrol
Resveratrol is a polyphenol that activates SIRT1 and has well-documented anti-inflammatory effects in cell and animal models. However, resveratrol suffers from very poor bioavailability in humans, and clinical trial results have been inconsistent. Ca-AKG has a clearer mechanism of action and potentially better bioavailability, though it has fewer published human studies overall.
Ca-AKG vs. CoQ10
Coenzyme Q10 supports the mitochondrial electron transport chain — a downstream function from where AKG acts in the TCA cycle. CoQ10 has decades of clinical research, particularly for heart health, but has not been specifically studied for epigenetic age modulation. They target different aspects of mitochondrial function.
Who Might Consider Ca-AKG?
Based on the available evidence, Ca-AKG supplementation may be most relevant for:
- Adults over 40 who are interested in longevity interventions and comfortable with early-stage evidence
- Individuals tracking biological age through DNA methylation testing who want to experiment with interventions
- People already engaged in healthspan optimization (exercise, nutrition, sleep) who are looking for additional tools
Ca-AKG is not recommended as a substitute for established healthy lifestyle practices. Exercise, sleep, nutrition, and stress management have far more evidence supporting their role in healthy aging than any supplement currently available.
The Bottom Line
Calcium alpha-ketoglutarate is one of the more scientifically interesting longevity supplements to emerge in recent years. Its mechanism of action — supporting TCA cycle function and epigenetic regulation through TET enzymes — is well-grounded in biochemistry. The mouse lifespan data from the Buck Institute is legitimate and encouraging, and the preliminary human biological age data is intriguing.
However, the human evidence is still thin. A single open-label study with 42 participants and no placebo control is not sufficient to make confident claims about biological age reversal. What we need — and what the field needs — are larger, randomized, placebo-controlled trials with longer follow-up periods.
If you choose to supplement with Ca-AKG, a dose of 1,000 mg/day appears reasonable based on existing data. Monitor your response, ideally with biological age testing if accessible, and don't expect miracles. The science is promising but early. That honest assessment serves you better than hype.
Frequently Asked Questions
See the FAQ section below for quick answers to the most common questions about Ca-AKG supplementation.